Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. by Titulaer, M, Lang, B, Verschuuren, J

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS by Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Willcox, N, Vincent, A, Irani, SR, Chapman, C

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders by Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Irani, S, Sabater, L, Graus, F, Murray, A, Chapman, C

The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis by Goevert, F, Becktepe, J, Balint, B, Varley, J, Irani, S, Titulaer, M, de Vries, J, Joubert, B, Honnorat, J, Rodriguez, HA, Dalmau, J, Deuschl, G, Leypoldt, F

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome by Titulaer, M, Maddison, P, Sont, J, Wirtz, P, Hilton-Jones, D, Klooster, R, Potman, M, Willcox, N, Smitt, P, Vincent, A, van der Maarel, S, Lang, B, Verschuuren, J

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. by Titulaer, M, Maddison, P, Sont, J, Wirtz, P, Hilton-Jones, D, Klooster, R, Willcox, N, Potman, M, Sillevis Smitt, P, Kuks, J, Roep, B, Vincent, A, van der Maarel, S, van Dijk, J, Lang, B, Verschuuren, J

A clinical approach to diagnosis of autoimmune encephalitis by Graus, F, Titulaer, M, Balu, R, Benseler, S, Bien, C, Cellucci, T, Cortese, I, Dale, R, Gelfand, J, Geschwind, M, Glaser, C, Honnorat, J, Höftberger, R, Iizuka, T, Irani, S, Lancaster, E, Leypoldt, F, Prüss, H, Rae-Grant, A, Reindl, M, Rosenfeld, M, Rostásy, K, Saiz, A, Venkatesan, A, Vincent, A, Wandinger, K, Waters, P, Dalmau, J